HuGE Literature Finder
Records
1
-
3
Pralatrexate in Combination with Oxaliplatin in Advanced Esophagogastric Cancer: A Phase II Trial with Predictive Molecular Correlates. Molecular cancer therapeutics 2019 Oct . Malhotra Usha, Mukherjee Sarbajit, Fountzilas Christos, Boland Patrick, Miller Austin, Patnaik Santosh, Attwood Kristopher, Yendamuri Sai, Adjei Araba, Kannisto Eric, Opyrchal Mateusz, Bushunow Peter, Loud Peter, Iyer Renuka, Khushalani Nikhil |
Pharmacogenetics of pemetrexed combination therapy in lung cancer: pathway analysis reveals novel toxicity associations. The pharmacogenomics journal 2014 Oct 14 (5): 411-7. Corrigan A, Walker J L, Wickramasinghe S, Hernandez M A, Newhouse S J, Folarin A A, Lewis C M, Sanderson J D, Spicer J, Marinaki A |
Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed-carboplatin. Lung cancer (Amsterdam, Netherlands) 2012 Oct 78 (1): 92-9. Tiseo Marcello, Giovannetti Elisa, Tibaldi Carmelo, Camerini Andrea, Di Costanzo Francesco, Barbieri Fausto, Burgers Jacobus A, Vincent Andrew, Peters Godefridus J, Smit Egbert F, Ardizzoni Andr |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 07, 2023
- Content source: